SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-007640
Filing Date
2024-05-09
Accepted
2024-05-09 16:46:11
Documents
82
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20240331x10q.htm   iXBRL 10-Q 1346338
2 EX-31.1 irwd-20240331xex31d1.htm EX-31.1 16576
3 EX-31.2 irwd-20240331xex31d2.htm EX-31.2 16635
4 EX-32.1 irwd-20240331xex32d1.htm EX-32.1 7974
5 EX-32.2 irwd-20240331xex32d2.htm EX-32.2 8409
  Complete submission text file 0001558370-24-007640.txt   6921703

Data Files

Seq Description Document Type Size
6 EX-101.SCH irwd-20240331.xsd EX-101.SCH 63250
7 EX-101.CAL irwd-20240331_cal.xml EX-101.CAL 65672
8 EX-101.DEF irwd-20240331_def.xml EX-101.DEF 280711
9 EX-101.LAB irwd-20240331_lab.xml EX-101.LAB 481392
10 EX-101.PRE irwd-20240331_pre.xml EX-101.PRE 431872
86 EXTRACTED XBRL INSTANCE DOCUMENT irwd-20240331x10q_htm.xml XML 1040550
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 24931512
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)